Yuheng Liu

This paper shows that mucosal mRNA vaccines protect against Kp pneumonia via Tc17 cells, not antibodies, and introduces an exosome platform enhancing vaccine efficacy.

The paper develops PoLixNano nanoparticles using machine learning to enhance mRNA delivery through nebulization, achieving high transfection efficiency and therapeutic efficacy in animal models.

This study shows airway mRNA vaccines need better purification and sequence design to avoid dsRNA contaminants, leading to improved immune responses.